Skip to main content

. 1983 Mar;15(3):390–392. doi: 10.1111/j.1365-2125.1983.tb01519.x

No significant effect of metoclopramide on misonidazole elimination in man.

K M Williams, E J Begg, D N Wade, K O'Shea

PMCID: PMC1427787 PMID: 6849772

390

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Dische S., Saunders M. I., Lee M. E., Adams G. E., Flockhart I. R. Clinical testing of the radiosensitizer Ro 07-0582: experience with multiple doses. Br J Cancer. 1977 May;35(5):567–579. doi: 10.1038/bjc.1977.90. [DOI] [PMC free article] [PubMed] [Google Scholar]
Saunders M. E., Dische S., Anderson P., Flockhart I. R. The neurotoxicity of misonidazole and its relationship to dose, half-life and concentration in the serum. Br J Cancer Suppl. 1978 Jun;3:268–270. [PMC free article] [PubMed] [Google Scholar]
Workman P., Bleehen N. M., Wiltshire C. R. Phenytoin shortens the half-life of the hypoxic cell radiosensitizer misonidazole in man: implications for possible reduced toxicity. Br J Cancer. 1980 Feb;41(2):302–304. doi: 10.1038/bjc.1980.43. [DOI] [PMC free article] [PubMed] [Google Scholar]
Workman P. Effects of pretreatment with phenobarbitone and phenytoin on the pharmacokinetics and toxicity of phenytoin on the pharmacokinetics and toxicity of misonidazole in mice. Br J Cancer. 1979 Sep;40(3):335–353. doi: 10.1038/bjc.1979.187. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES